What new warnings were added to lipitor's label?

Two major warnings were added to Lipitor (atorvastatin) labeling in the past years:

- Cognitive effects: There have been reports of memory loss, confusion, amnesia, or other cognitive problems in some people taking statins. These events are generally rare and reversible after stopping the medication or with dose adjustment. The label warns to monitor for such symptoms and consult a clinician if they occur.

- Increased blood sugar and risk of diabetes: The label notes a small increased risk of elevated blood sugar and new-onset diabetes mellitus in some patients, especially those with underlying risk factors. Clinicians are advised to weigh the benefits and risks, and monitor blood glucose as appropriate.

Other longstanding warnings remain on the Lipitor label (e.g., risk of myopathy/rhabdomyolysis, liver enzyme elevations, and potential drug interactions with certain medicines), but the two above are the typically cited “new” warnings added in recent updates.

If you’d like, I can pull the exact current wording from the latest FDA/label database or give you the precise label sections.